GlassScriptPhysician profile
Lauryn Ann Benninger
NPI 1487072211
$923.95
in general payments reported to CMS, 2019-2025
9 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $279 · 2023: $271 · 2024: $134 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $366.12 | 2022-2023 | Tobi Podhaler |
| Insmed, INC. | $223.97 | 2021-2022 | |
| Genzyme Corporation | $123.06 | 2025 | |
| Aimmune Therapeutics, INC. | $98.41 | 2024 | |
| Genentech USA, INC. | $44.42 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.99 | 2023-2024 | Trikafta |
| Baxter Healthcare | $18.52 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $16.46 | 2025 | Nucala |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauryn Benninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.